Douglas Pereira Pinto

4PUBLICATIONS
26CO-AUTHORS
PharmacogenomicsMolecular targetsMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 08, 2025
Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice.

Mayara Mattos, Carolina Q Sacramento, André C Ferreira

|Jan 21, 2022
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.

Otávio Augusto Chaves, Carolina Q Sacramento, André C Ferreira

Pageof 1